Metabolomics for clinical use and research in chronic kidney disease (Q38750287)

6 September 2017

Metabolomics for clinical use and research in chronic kidney disease (English)

1 reference

6 September 2017

1 reference

Berthold Hocher

1

0 references

Jerzy Adamski

series ordinal

2

object named as

Jerzy Adamski

1 reference

PubMed ID

28262773

6 September 2017

language of work or name

English

0 references

publication date

6 March 2017

1 reference

Nature Reviews Nephrology

6 September 2017

1 reference

6 September 2017

13

1 reference

6 September 2017

5

1 reference

6 September 2017

269-284

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2017.30

6 September 2017

0 references

cites work

Prevalence of chronic kidney disease in population-based studies: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The impact of CKD identification in large countries: the burden of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Cystatin C as a biomarker for estimating glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Impact of thyroid dysfunction on serum cystatin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Targets, trends, excesses, and deficiencies: refocusing clinical investigation to improve patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The use of metabolomics in population-based research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The emergent role of metabolic phenotyping in dynamic patient stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

LIPID MAPS online tools for lipid research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

HMDB: a knowledgebase for the human metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Defining the metabolome: size, flux, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome' rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The dynamic range of the human metabolome revealed by challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Long term conservation of human metabolic phenotypes and link to heritability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Type 2 diabetes is associated with postprandial amino acid measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomic analysis of plasma metabolites that may mediate effects of rye bread on satiety and weight maintenance in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Alcohol-induced metabolomic differences in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Human serum metabolic profiles are age dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomic markers reveal novel pathways of ageing and early development in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Plasma metabolomic profiles enhance precision medicine for volunteers of normal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics: an emerging post-genomic tool for nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Application of NMR metabolomics to search for human disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Mass spectrometers for the analysis of biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Mass spectrometric based approaches in urine metabolomics and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Using high-resolution quadrupole TOF technology in DMPK analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Innovation in metabolomics to improve personalized healthcare

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Developments in FTICR-MS and Its Potential for Body Fluid Signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Human metabolic individuality in biomedical and pharmaceutical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The human serum metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The human urine metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics insights into pathophysiological mechanisms of nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Biomarkers and personalized therapy in chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Statistical methods for the analysis of high-throughput metabolomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Analytical and statistical approaches to metabolomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Missing value imputation strategies for metabolomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Imputation of data values that are less than a detection limit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A statistical framework for biomarker discovery in metabolomic time course data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Biomarkers in chronic kidney disease, from kidney function to kidney damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Biomarkers in chronic kidney disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolic biomarkers for chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Dimethylarginines in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Role of asymmetrical dimethylarginine in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Association of Asymmetric Dimethylarginine With Acute Pancreatitis-Induced Hyperglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Formation of Melatonin and 5-Hydroxyindole Acetic Acid from 14C-Tryptophan by Rat Pineal Glands in Organ Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Niacin and progression of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Cross-Talk Between NO Synthase Isoforms in Neuro-Inflammation: Possible Implications in HIV-Associated Neurocognitive Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Nitric oxide deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

L-Arginine and its metabolites in kidney and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

21 January 2018

The function of spermine

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Aliphatic polyamines in physiology and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Association of advanced age with concentrations of uraemic toxins in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Plasma metabolomic profiles in different stages of CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Role of phosphatidylinositol 3,4,5-trisphosphate in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Lipidomic analysis of signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Ceramides - Lipotoxic Inducers of Metabolic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Eicosanoid storm in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolite profiling reveals new insights into the regulation of serum urate in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Serum metabolite concentrations and decreased GFR in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Update of the LIPID MAPS comprehensive classification system for lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

L-carnitine supplementation and physical exercise restore age-associated decline in some mitochondrial functions in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The aging eye and the role of L-carnitine and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A mitochondrial carnitine acylcarnitine translocase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Regulation of the activity of caspases by L-carnitine and palmitoylcarnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Steroid hormone synthesis in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Recent advances in 17beta-hydroxysteroid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Stress hormone and male reproductive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Serum metabolomic profiling and incident CKD among African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Carcinogenesis studies of cresols in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The effects of butylated hydroxyanisole and butylated hydroxytoluene on renal function in the rat. I. Effects on fluid and electrolyte excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Toxicity of free p-cresol: a prospective and cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

p-Cresol mediates autophagic cell death in renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Cytotoxic effects of p-cresol in renal epithelial tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Genome-wide association studies with metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A new equation to estimate glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A combined epidemiologic and metabolomic approach improves CKD prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identifying early urinary metabolic changes with long-term environmental exposure to cadmium by mass-spectrometry-based metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabonomics evaluation of urine from rats administered with phorate under long-term and low-level exposure by ultra-performance liquid chromatography-mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identification of aristolochic acid in Chinese herbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Plasma metabolic profiling analysis of nephrotoxicity induced by acyclovir using metabonomics coupled with multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A metabolomics-based approach for predicting stages of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The role of metabolomics in neonatal and pediatric laboratory medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Effects of pre-analytical processes on blood samples used in metabolomics studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Pre-analytical sample quality: metabolite ratios as an intrinsic marker for prolonged room temperature exposure of serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Endogenous metabolites and inflammasome activity in early childhood and links to respiratory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

NMR-Based Metabolic Snapshot from Minibronchoalveolar Lavage Fluid: An Approach To Unfold Human Respiratory Metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomics as a potential new approach for investigating human reproductive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Orthogonal projections to latent structures (O-PLS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food Challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: Relationship with oxidative stress improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Acetyl-carnitine in Heart and Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Carnitine as a Fatty Acid Carrier in Intermediary Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Assay Tools for Metabolomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Use of Ranks in One-Criterion Variance Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolism of isomers of 3-hydroxykynureninec14 to quinolinic acid, niacin metabolites and carbon dioxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Quantitative studies on the urinary excretion of indoxyl sulfate (indican) in man following administration of L-tryptophan and acetyl-L-tryptophan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Nitric oxide: what's new to NO?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Modulation of Local and Systemic Heterocellular Communication by Mechanical Forces: A Role of Endothelial Nitric Oxide Synthase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Lipid mediator networks in cell signaling: update and impact of cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Oxidative stress in chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Oxidative Stress in Kidney Transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Chlorocresol and chloracetamide: allergens in medications, glues, and cosmetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Serum metabolomics study of the acute graft rejection in human renal transplantation based on liquid chromatography-mass spectrometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Amino Acid and Protein Metabolism in Diabetes Mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Metabolomic composition of normal aged and cataractous human lenses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

inferred from DOI database lookup

7 January 2021

based on heuristic

Oxidative stress in kidney transplantation: malondialdehyde is an early predictive marker of graft dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.30

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2017.30

1 reference

PubMed ID

28262773

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

28262773